The oncologic predisposition conferred by the NF1 mutation refers to the development of benign and malignant tumors; in particular, in childhood, the risk is increased for gliomas of the optic pathway, juvenile myelomonocytic leukemia, and embryonal rhabdomyosarcomas [16,17]. The gene discussed is NF1; the disease is cancer.